We found that SRSF9 depletion repressed tumorigenesis (Fig. 3K) and resulted in tumor volumes that were noticeably lower than those in the negative control group (Fig. 3L), suggesting that SRSF9 exerts its oncogenic role in CRC by regulating cell growth in vivo. This evidence concerns the gene SRSF9 and colorectal carcinoma.